|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | SLC26A4 mutation testing for hearing loss associated with enlargement of the vestibular aqueduct显示文摘Pendred syndrome(PS) is characterized by autosomal recessive inheritance of goiter associated with a defect of iodide organification, hearing loss, enlargement of the vestibular aqueduct(EVA), and mutations of the SLC26A4 gene. However, not all EVA patients have PSor SLC26A4 mutations. Two mutant alleles of SLC26A4 are detected in 1/4 of North American or European EVA populations, one mutant allele is detected in another 1/4 of patient populations, and no mutations are detected in the other 1/2. The presence of two mutant alleles of SLC26A4 is associated with abnormal iodide organification, increased thyroid gland volume, increased severity of hearing loss, and bilateral EVA. The presence of a single mutant allele of SLC26A4 is associated with normal iodide organification, normal thyroid gland volume, less severe hearing loss and either bilateral or unilateral EVA. When other underlying correlations are accounted for, the presence of a cochlear malformation or the size of EVA does not have an effect on hearing thresholds. This is consistent with observations of an Slc26a4 mutant mouse model of EVA in which hearing loss is independent of endolymphatic hydrops or inner ear malformations. Segregation analyses of EVA in families suggest that the patients carrying one mutant allele of SLC26A4 have a second, undetected mutant allele of SLC26A4, and the probability of a sibling having EVA is consistent with its segregation as an autosomal recessive trait. Patients without any mutations are an etiologically heterogeneous group in which siblings have a lower probability of having EVA. SLC26A4 mutation testing can provide prognostic information to guide clinical surveillance and management, as well as the probability of EVA affecting a sibling. | Taku Ito Julie Muskett Parna Chattaraj Byung Yoon Choi Kyu Yup Lee Christopher K Zalewski Kelly A King Xiangming Li Philine Wangemann Thomas Shawker Carmen C Brewer Seth L Alper Andrew J Griffith | 2013 | World Journal of Otorhinolaryngology2013，3，2： | 2 |
| 2 | Interleukin-lbeta inhi- bition and the prevention of recurrent cardiovascular events : ration- ale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) 显示文摘 | Ridker PM Thuren T Zalewski A | 2011 | Am Heart J2011，162，4： | 1 |
| 3 | Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target显示文摘 | Macphee CH Nelson J Zalewski A | 2006 | Curr Opin Pharmacol2006，6，2： | 1 |
| 4 | Human epicardial adipose tissue is a source of inflammatory mediators 显示文摘 | Mazurek T Zhang L Zalewski A | 2003 | Circulation2003，108，20： | 1 |
| 5 | Spectral resPonse self-calibration and interpolation of silicon photodiodes 显示文摘 | Geist J Zalewski E F Schaefer A R | 1980 | Applied Optics1980，19，22： | 1 |
| 6 | MDR - 1 gene polymorphisms and clinical course of steroid - responsive nephrotic syndrome in children显示文摘 | Wasilewska A Zalewski G Chyczewski L | 2007 | Pediatr Nephrol2007，22，1： | 1 |
| 7 | Lipoprotein-associated phospholipase A2(Lp-PLA2) activity, an emerging CV risk marker, can be inhibited in atherosclerotic lesions and plasma by novel phar- macologic intervention : The results of a muhicenter clinical study显示文摘 | Johnson A Zalewski A Janmohamed S | 2004 | Circulation2004，110，： | 1 |
| 8 | Interleukin-1 beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) 显示文摘 | Ridker PM Thuren T Zalewski A | 2011 | Am Heart J2011，162，4： | 1 |
| 9 | Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target显示文摘 | Macphee CH Nelson J Zalewski A | 2006 | Curr Opin Pharmacol2006，6，2： | 1 |
| 10 | Role of lipoprotein-associated phospholipase A(2) in atherosclerosis-Biology,epidemiology,and possible therapeutic target显示文摘 | Zalewski A Macphee C | 2005 | Arterioscler Thromb Vasc Biol2005，25，5： | 1 |
| 11 | MDR- 1 gene polymorphisms and clinical course of steroid- responsive nephrotic syndrome in children 显示文摘 | Wasilewska A Zalewski G Chyczewski L | 2007 | Pediatr Nephrol2007，22，1： | 1 |
| 12 | Human epieardial adipose tissue is a source of inflammatory mediators 显示文摘 | Mazurek T Zhang L Zalewski A | 2003 | Circulation2003，108，20： | 1 |
| 13 | Human epicardial adipose tissue is a source of inflammatory mediators显示文摘 | MAZUREK T ZHANG L ZALEWSKI A | 2003 | Circulation2003，108，： | 1 |
| 14 | Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target显示文摘 | Macphee CH Nelson J Zalewski A | 2006 | Curr Opin Pharmacol2006，6，2： | 1 |
| 15 | Expression of extracellular matrix components is disrupted in the immature and adult es- trogen receptor ~ -null mouse ovary显示文摘 | Zalewski A Cecchini E L Deroo B J | 2012 | PLOS One2012，7，29： | 1 |
| 16 | Role of lipoprotein-associated phospholipase A2 in atherosclerosis:biology,epidemiology,and possible therapeutic target显示文摘 | Zalewski A Macphee C | | 0，，05： | 1 |
| 17 | Cutting balloon angio-plasty for the treatment of multivessel coronary artery disease in a pa-tient with unstable angina 显示文摘 | Pawlowski T Dejryng K Zalewski A | 2011 | Kardiol Pol2011，69，2： | 1 |
| 18 | Interleukin-1β inhibition and the prevention of recurrent cardiovascular events : rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) 显示文摘 | Ridker P M Thuren T Zalewski A | 2011 | Am Heart J2011，162，4： | 1 |
| 19 | Inter- leukin-1 J3 inhibition and the prevention of recurrent cardio- vascular events: Rationale and Design of the Canakinumab An- ti-inflammatory Thrombosis Outcomes Study (CANTOS)显示文摘 | RIDKER PM THUREN T ZALEWSKI A | 2011 | Am Heart J2011，162，4： | 1 |
| 20 | Human epicardial adipose tissue is a source of inflammatory mediators显示文摘 | Mazurek T Zhang L Zalewski A | 2003 | Circulation2003，108，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员